openPR Logo
Press release

Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Market Size, Share, Impressive Industry Growth, Report 2027

10-22-2021 08:58 AM CET | Health & Medicine

Press release from: Orion Market Research

The global dipeptidyl peptidase 4 (DPP-4) inhibitors market is anticipated to grow significantly at a CAGR of 3.5% over the forecast period (2020-2026). The global dipeptidyl peptidase 4 (DPP-4) inhibitors market is sectioned on the basis of drug type. The market is sectioned as Sitagliptin, Vildagliptin, Saxagliptin, Linagliptin, Gemigliptin, Anagliptin, Teneligliptin, and Others. Amongst these drug types of the global dipeptidyl peptidase 4 (DPP-4) inhibitors, the Sitagliptin and Saxagliptin are projected to hold the most lucrative share in the market. The key aspects that drive the segmental growth of the dipeptidyl peptidase 4 (DPP-4) inhibitors market include the effectiveness of the drugs. As per the NCBI NLM, the Sitagliptin and Saxagliptin drugs hold the lucrative share in the market owing to their effectiveness on the patients.

A full report of Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Market is available at: https://www.omrglobal.com/industry-reports/dipeptidyl-peptidase-4-inhibitors-market

There has been an upsurge witnessed in the prevalence of diabetes across the globe. As per the WHO, over the last three decades there has been an upsurge in the prevalence of diabetes. As per the IDF, the cases of diabetic were nearly 463 million across the globe in 2019. The cases are projected to increase which is expected to rise to 578 million by 2030 and nearly 700 million by 2045. An increase in the prevalence of diabetes is likely to demand the proper drugs for the treatment. Thus, owing to the market is likely to witness an upsurge over the forecast period.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/dipeptidyl-peptidase-4-inhibitors-market

Market Coverage

• Market number available for – 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Type
• Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
• Competitive Landscape- Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Merck & Co., Eli Lily & Co., GlaxoSmithKline Plc, LG Life Sciences Ltd., Novartis AG, Phenomix Corp., and Takeda Pharmaceutical Co. among others

Key questions addressed by the report

• What is the market growth rate?
• Which segment/region dominates the market in base year?
• Which segment/region will project fastest growth in the market?
• How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region/segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Dipeptidyl peptidase 4 (DPP-4) inhibitors Market – Segmentation

By Type

• Sitagliptin
• Vildagliptin
• Saxagliptin
• Linagliptin
• Gemigliptin
• Anagliptin
• Teneligliptin
• Others

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/dipeptidyl-peptidase-4-inhibitors-market

Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Market– Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• AstraZeneca Plc
• Boehringer Ingelheim International GmbH
• Bristol Myers Squibb Co.
• Eli Lily & Co.
• GlaxoSmithKline Plc
• Kowa Co. Ltd.
• LG Life Sciences Ltd.
• Merck & Co.
• Novartis AG
• Pfizer Inc.
• Phenomix Corp.
• Sanofi SA
• Sanwa Kagaku Kenkyusho Co. Ltd.
• SatRx LLC
• Takeda Pharmaceutical Co.

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Market Size, Share, Impressive Industry Growth, Report 2027 here

News-ID: 2437632 • Views:

More Releases from Orion Market Research

Growing demand for Advanced Insurance Channels is Propelling the Insurance Platform Market
Growing demand for Advanced Insurance Channels is Propelling the Insurance Platf …
The global insurance platform market is anticipated to grow at a CAGR of 13.0% during the forecast period (2024-2031). The market growth is driven by the growing demand for advanced insurance channels, as they facilitate convenient and accessible interactions with insurance companies. Additionally, the rise in the adoption of cloud-based digital solutions supports the market to gain a competitive advantage. Get Free Sample link @ https://www.omrglobal.com/request-sample/insurance-platform-market The global insurance platform
Growing Preference for Outdoor Adventure is Propelling the Sleeping Bag Market
Growing Preference for Outdoor Adventure is Propelling the Sleeping Bag Market
The global sleeping bag market is anticipated to grow at a considerable CAGR of 6.7% during the forecast period (2024-2031). The market growth is driven by the growing demand for outdoor activities and the rising market of adventure tourism. Additionally, the rise in disposable income is contributing to the market growth. The global sleeping bag market is segmented by insulation type (into down, synthetic), by size (into kids, long, and
Depleting Oil Reserves are Accelerating the Demand for Enhanced Oil Recovery
Depleting Oil Reserves are Accelerating the Demand for Enhanced Oil Recovery
The global Enhanced Oil Recovery (EOR) market is anticipated to grow at a CAGR of 6.9% during the forecast period (2024-2031). The market growth is driven by the rising global energy demand, owing to population expansion, industrialization, and urban development. Additionally, the rising concern of depleting conventional oil reserves is increasing reliance on EOR techniques to optimize production. Furthermore, technological advancements, stringent environmental regulations, and the demand for sustainable energy
Growing Applications in Electronics and Connected Devices is Driving Printed Electronics Market
Growing Applications in Electronics and Connected Devices is Driving Printed Ele …
The global printed electronics market is estimated to grow at a significant CAGR of 18.3% during the forecast period (2024-2031). The market growth is driven by the rising demand for printed electronics for connected devices. The rising demand for flexible electronic components in consumer electronics is additionally contributing to the market growth. Furthermore, printed electronics are becoming more cost-efficient and flexible, leading to increasing applications of the products in lighting,

All 5 Releases


More Releases for Sitagliptin

Sitagliptin Market Demand And Growth Analysis 2022 to 2027
Sitagliptin Market - Insights In 2022: Based In the end-use industry, "Sitagliptin Market" 2022 is segmented into Diabetes, Epilepsys. The Sitagliptin Market Report Provides an In-depth Key analysis of Industry characteristics, size, growth rate, segmentation, regional and country analysis, competitive landscape, company shares, development trends, and business strategies for this market. This report records historical and forecasts market by region with its customer demographics which forms the core of any
Global Sitagliptin Drug Market Trends, Market Share, Industry Size, Growth, Oppo …
The sitagliptin drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Sitagliptin drug is used for the treatment of type 2 diabetes. It is a white non-hygroscopic powder somewhat crystalline in nature. Insulin is a type of hormone which is produced naturally in the body. Production of insulin takes place in the pancreas. Insulin is responsible to control the blood sugar level in the
Sitagliptin Market Size, Share, Trends, Growth, Forecast Report 2027 | Valuates …
The global Sitagliptin market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Sitagliptin, sold under the brand name Januvia among others, is a medication used to treat diabetes mellitus type 2. The advantage of sitagliptin is that it has fewer side effects when controlling the glucose content in the blood. The global
Global Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Market 2021-2027: Industry Anal …
The global dipeptidyl peptidase 4 (DPP-4) inhibitors market is anticipated to grow significantly at a CAGR of 3.5% over the forecast period (2020-2026). The global dipeptidyl peptidase 4 (DPP-4) inhibitors market is sectioned on the basis of drug type. The market is sectioned as Sitagliptin, Vildagliptin, Saxagliptin, Linagliptin, Gemigliptin, Anagliptin, Teneligliptin, and Others. Amongst these drug types of the global dipeptidyl peptidase 4 (DPP-4) inhibitors, the Sitagliptin and Saxagliptin are
Global Sitagliptin Market 2020-2024 Flourishing with Merck, Yonta, Haikang Pharm …
The growing demand for Sitagliptin has provided a major boost to the Global Sitagliptin Market as more people are shifting their preferences to this growing sector. The market is expected to keep rising at a high CAGR and reach values of high millions by the end of the forecast period of 2020 up to 2024. Overview of Global Sitagliptin Market: Sitagliptin, sold under the brand name Januvia among others, is a medication
Sitagliptin Phosphate Market : Upcoming Demands & Growth Analysis (2019-2024)
The global market size of Sitagliptin phosphate is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024. Global Sitagliptin phosphate Market Report 2019 - Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Sitagliptin phosphate industry.